SCHEMBL5160138

SCHEMBL5160138

CN(C)c1ccc(CNC(=O)N(CCc2ccccc2)C(=O)CCC(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
ALOX15 P16050 2/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
NFKB1 P19838 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
MCL1 Q07820 1/20 0.44
KDM4E B2RXH2 4/20 0.44
GAA P10253 2/20 0.44
HPGD P15428 1/20 0.44
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5158167 0.93 ALDH1A1 (0.46) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL5160351 0.87 EPHX2 (0.46) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL5160873 0.85 MAPT (0.57) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL5159890 0.84 ALDH1A1 (0.41) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL5163832 0.79 ALDH1A1 (0.41) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL5163048 0.78 ALDH1A1 (0.58) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL29221815 0.73 KMT2A (0.61) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL5494954 0.72 LMNA (0.45) SMN1; SMN2NPC1MAPK1RAB9AGAA
SCHEMBL5162886 0.70 ALDH1A1 (0.60) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1
SCHEMBL472281 0.70 FFAR1 (0.59) ALDH1A1ALOX15MAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753733-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES Avanir Pharmaceuticals (US) 2007-02-21 EP claimed
WO-2005123700-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO claimed
EP-1753733-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES Avanir Pharmaceuticals (US) 2007-02-21 EP disclosed
WO-2005123700-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO disclosed